Encompass Health
EHC110.9000.36% ( +0.400 )
Q2 FY2026 EarningsQ2 FY26 results beat consensus across key metrics: revenue of $1,597.4M vs. $1,571.3M expected, and Adjusted EPS of $1.55 vs. $1.48 consensus. Revenue growth of 9.6% YoY was driven by a 5.6% increase in discharges and a 3.9% rise in revenue per discharge. Management raised FY26 guidance for revenue, Adjusted EBITDA, and Adjusted EPS, while increasing the share repurchase authorization to $1 billion.
Financial report interval: 2026.03.30 - 2026.06.30
Preview: Encompass Health(EHC) predict that the Revenue is 1.597 B (+9.58%), Beat estimate;the EBIT is 257.6 M (+7.92%), Beat estimate;the EPS is 1.54 (+10.79%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
1.60B9.58%
1.57B7.79%
+0.03B1.79%
EBITExceed expectations
0.26B7.92%
0.26B7.86%
+0.00B0.06%
EPSExceed expectations
1.5410.79%
1.46295.24%
+0.07715.55%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf